Search
for
Sort by
Research 361–390 of 1000+
- Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
- Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial
- Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome
- Metformin in dermatology: an overview
- Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome
- Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
- The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome
- Metformin influence on hormone levels at birth, in PCOS mothers and their newborns
- The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome
- Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome
- Metformin protects against gentamicin-induced hair cell death in vitro but not ototoxicity in vivo
- Metformin improved health-related quality of life in ethnic Chinese women with polycystic ovary syndrome
- Impact of Treatment with Rosiglitazone or Metformin on Biomarkers for Insulin Resistance and Metabolic Syndrome in Patients with Polycystic Ovary Syndrome
- Serum vascular endothelial growth factor B is elevated in women with polycystic ovary syndrome and can be decreased with metformin treatment
- The Utility of Metformin Therapy in Reproductive-Aged Women with Polycystic Ovary Syndrome (PCOS)
- The Relationship Between Metformin and Serum Prostate‐Specific Antigen Levels
- Use of metformin in pediatric age
- Efficacy of metformin therapy in adolescent girls with androgen excess: relation to sex hormone–binding globulin and androgen receptor polymorphisms
- Development of a new GC–MS/MS method for the determination of metformin in human hair
- The Effect of Alfacalcidiol and Metformin on Phenotype Manifestations in Women with Polycystic Ovary Syndrome – a Preliminary Study
- The investigation and management of severe hyperandrogenism pre- and postmenopause: Non-tumor disease is strongly associated with metabolic syndrome and typically responds to insulin-sensitization with metformin
- Metformin and Malignant Tumors: Not Over the Hill
- Update on the therapeutic role of metformin in the management of polycystic ovary syndrome: Effects on pathophysiologic process and fertility outcomes
- Association between Polymorphisms of OCT1 and Metabolic Response to Metformin in Women with Polycystic Ovary Syndrome
- The guidelines issued by the European Society for Human Reproduction and Embryology and the American Society for Reproductive Medicine regarding the induction of ovulation with metformin in patients with the polycystic ovary syndrome potentially require reconsideration
- The effect of alfacalcidiol and metformin on metabolic disturbances in women with polycystic ovary syndrome
- Metformin as an adjunct therapy for the treatment of moderate to severe acne vulgaris
- Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome
- Effect of Type 2 Diabetes Mellitus on the Pharmacokinetics of Metformin in Obese Pregnant Women
- Hyperandrogenism and menstrual imbalance are the best predictors of metformin response in PCOS patients